https://www.businesswire.com/news/home/20251204253955/en/IDE034-a-Bispecific-ADC-Licensed-by-Biocytogen-to-IDEAYA-Receives-FDA-IND-Clearance
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision onc...
https://www.businesswire.com/news/home/20260401578734/en/Biocytogen-and-Sihuan-Pharmaceutical-Announce-Strategic-Partnership-in-Weight-Loss-and-Beyond
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and developmen...
strategic partnershipweight losspharmaceuticalannounce
https://www.businesswire.com/news/home/20260401580773/en/Biocytogen-and-Sihuan-Pharmaceutical-Announce-Strategic-Partnership-in-Weight-Loss-and-Beyond
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and developmen...
strategic partnershipweight losspharmaceuticalannounce
https://www.businesswire.com/news/home/20231218991664/en/Biocytogen-Enters-into-Antibody-Agreement-with-Ona-Therapeutics-to-Develop-Antibody-Drug-Conjugates-Targeting-Solid-Tumors
Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech company focusing on the discovery and development of novel antib...